S1 Biopharma
NY - New YorkPharmaceutical
Focus: S1 Biopharma is a pharmaceutical company focused on women's sexual health and metabolic diseases, headquartered in New York. The company is in clinical-stage development with a small pipeline of early-phase assets.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About S1 Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow S1 Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
bupropion, Lorexys low-dose, Lorexys moderate-dose
Hypoactive Sexual Desire Disorder (DSM-IV-TR Defined)Clinical Trials (1)
NCT01857596Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety
Phase 1/2Help build intelligence for S1 Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.